OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
Liang Hai-feng, Xin Du, Yingchun Zhou, et al.
Medical Science Monitor (2019) Vol. 25, pp. 4691-4698
Open Access | Times Cited: 14
Liang Hai-feng, Xin Du, Yingchun Zhou, et al.
Medical Science Monitor (2019) Vol. 25, pp. 4691-4698
Open Access | Times Cited: 14
Showing 14 citing articles:
Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation
Yutao Guo, Deirdre A. Lane, Limin Wang, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 13, pp. 1523-1534
Closed Access | Times Cited: 278
Yutao Guo, Deirdre A. Lane, Limin Wang, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 13, pp. 1523-1534
Closed Access | Times Cited: 278
Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
Dana Prídavková, Matej Samoš, Tomáš Bolek, et al.
Journal of Diabetes Research (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 13
Dana Prídavková, Matej Samoš, Tomáš Bolek, et al.
Journal of Diabetes Research (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 13
Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study)
M. Rosa Dalmau Llorca, Carina Aguilar Martín, Noèlia Carrasco-Querol, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 11, pp. 5700-5700
Open Access | Times Cited: 11
M. Rosa Dalmau Llorca, Carina Aguilar Martín, Noèlia Carrasco-Querol, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 11, pp. 5700-5700
Open Access | Times Cited: 11
Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry
Amaya García-Fernández, María Asunción Esteve‐Pastor, Inmaculada Roldán‐Rabadán, et al.
Annals of Medicine (2020) Vol. 52, Iss. 6, pp. 300-309
Open Access | Times Cited: 10
Amaya García-Fernández, María Asunción Esteve‐Pastor, Inmaculada Roldán‐Rabadán, et al.
Annals of Medicine (2020) Vol. 52, Iss. 6, pp. 300-309
Open Access | Times Cited: 10
Real-world investigation on discontinuation of oral anticoagulation after paroxysmal atrial fibrillation catheter ablation in China
Ronghui Yu, Hui Xi, Jun Lu, et al.
Annals of Palliative Medicine (2020) Vol. 9, Iss. 3, pp. 940-946
Open Access | Times Cited: 7
Ronghui Yu, Hui Xi, Jun Lu, et al.
Annals of Palliative Medicine (2020) Vol. 9, Iss. 3, pp. 940-946
Open Access | Times Cited: 7
Effects of angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on one-year outcomes of patients with atrial fibrillation: insights from a multicenter registry study in China.
Si‐qi Lyu, Yanmin Yang, Jun Zhu, et al.
PubMed (2020) Vol. 17, Iss. 12, pp. 750-758
Closed Access | Times Cited: 4
Si‐qi Lyu, Yanmin Yang, Jun Zhu, et al.
PubMed (2020) Vol. 17, Iss. 12, pp. 750-758
Closed Access | Times Cited: 4
Effectiveness and Safety of the Coadministration of Rifampin and Warfarin versus Direct Oral Anticoagulants: A Cohort Study
Ju-Chieh Wung, Chia‐Chen Hsu, C.J. Wang, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access
Ju-Chieh Wung, Chia‐Chen Hsu, C.J. Wang, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access
The Characteristics, Long-Term Outcomes, Risk Factors, and Antithrombotic Therapy in Chinese Patients With Atrial Fibrillation and Bioprosthetic Valves
Jiameng Ren, Yanmin Yang, Jun Zhu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 3
Jiameng Ren, Yanmin Yang, Jun Zhu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 3
Non-Clinical Factors Associated with International Normalized Ratio Control in Patients on Warfarin Therapy: A Review Paper
Tharani Ramasamy, Naganathan Kathiresan Pillai, Christina Gertrude Yap, et al.
OALib (2020) Vol. 07, Iss. 11, pp. 1-21
Open Access | Times Cited: 2
Tharani Ramasamy, Naganathan Kathiresan Pillai, Christina Gertrude Yap, et al.
OALib (2020) Vol. 07, Iss. 11, pp. 1-21
Open Access | Times Cited: 2
Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry
José Miguel Rivera‐Caravaca, Lina Badimón, Ignacio Ferreira‐González, et al.
EP Europace (2021) Vol. 24, Iss. 1, pp. 4-11
Closed Access | Times Cited: 2
José Miguel Rivera‐Caravaca, Lina Badimón, Ignacio Ferreira‐González, et al.
EP Europace (2021) Vol. 24, Iss. 1, pp. 4-11
Closed Access | Times Cited: 2
The outcome of three-factor Prothrombin Complex Concentrate (3F-PCC) in warfarin reversal: A single center retrospective cohort study
Hock Peng Koh, Nirmala Jagan, Szu Lynn Tay, et al.
Thrombosis Update (2020) Vol. 1, pp. 100014-100014
Open Access | Times Cited: 1
Hock Peng Koh, Nirmala Jagan, Szu Lynn Tay, et al.
Thrombosis Update (2020) Vol. 1, pp. 100014-100014
Open Access | Times Cited: 1
Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial
Litao Zhang, Sha Li, Zishuo Li, et al.
Cardiovascular Therapeutics (2023) Vol. 2023, pp. 1-10
Open Access
Litao Zhang, Sha Li, Zishuo Li, et al.
Cardiovascular Therapeutics (2023) Vol. 2023, pp. 1-10
Open Access
Integrating Real-World Evidence in Economic Evaluation of Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation in a Developing Country
M. Sakil Syeed, Teerawat Nonthasawadsri, Richard E. Nelson, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 2, pp. 173-183
Closed Access
M. Sakil Syeed, Teerawat Nonthasawadsri, Richard E. Nelson, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 2, pp. 173-183
Closed Access
Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
Fang Ma, Yuan Li, Xinli Wen, et al.
Clinical and Applied Thrombosis/Hemostasis (2022) Vol. 28
Open Access
Fang Ma, Yuan Li, Xinli Wen, et al.
Clinical and Applied Thrombosis/Hemostasis (2022) Vol. 28
Open Access
